IPPRA / Grant Monitor

2026-07-07
← Board

DoW Arthritis Translational Research Award

HT942526ATRPTRA · Defense Health Agency Contracting Activity - DHACA

biomedical clinical public health education workforce Science & Technology R&D

Closes
2026-10-22 · 107 d
Award ceiling
Award floor
Program funding
$1,600,000
Expected awards
2
Cost sharing
No
Posted
2026-05-01
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

Supports hypothesis-driven translational arthritis research using preclinical or animal studies to produce clinically relevant advances for Service Members, Veterans, their Families, and the public.

Funds
applied research
University
direct
physical sciences
minor
engineering
minor
life biomedical
central
computational data
minor

⚑ Basic research not allowed · Clinical research and clinical trials not allowed · Preliminary and/or published data required · Award favors high-impact translational impact; preclinical or animal research emphasized

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 55 good technical depth: minor; funds applied research
IPPRA 45 partial peripheral portfolio topic: public_health; social/behavioral work is none; funds applied research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); capped at 45 (limited social-science role)
Tom Love Innovation Hub 30 weak funds applied research; deep-tech content

Description

Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Translational Research Award (TRA) supports high-impact translational research that will accelerate critical findings into clinically relevant solutions. Research funded under this award mechanism will be hypothesis-driven, high-impact applied research that is relevant to Service Members, Veterans, their Families and the American public. Research addressing any and all types of arthritis is encouraged.

Distinctive Features: The FY26 ATRP TRA mechanism is intended to support preclinical or animal research and may not be used for clinical research or clinical trials. Basic research, as defined in Section 3.1.2, is not allowed. A key aspect of this award mechanism is impact. The application should explicitly state how outcomes of the proposed research will significantly advance arthritis research, particularly in accelerating critical findings into clinically relevant solutions.

Preliminary and/or published data, originating from research conducted by the applicant(s) or others, is required.

Apply

View on Grants.gov → CONTACT: JoAnn Martin Grantor <help@eBRAP.org>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · Department of Defense (BAA-style) conventions SEE A DOD EXAMPLE →

Funder-faithful document skeletons — Department of Defense (BAA-style)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING